Skip to content
Mesothelioma.net
phone iconCall1-800-692-8608 chat icon Chat 24/7 Live Chat
Menu
  • Malignant Mesothelioma
    • About Mesothelioma
      • How to Survive Mesothelioma
      • 100 Questions & Answers about Mesothelioma (Free Book)
      • Symptoms
      • Diagnosis
      • Prognosis
      • Life Expectancy
    • Types
      • Pleural
      • Peritoneal
      • Epithelioid
      • Sarcomatoid
      • Biphasic
    • Stages
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
    • Additional Information
      • Causes
      • Asbestos and Its Dangers
      • Facts
      • Support
      • Financial Compensation
      • FREE Mesothelioma Packet
  • Treatment
    • Treatment Options
      • Surgery
      • Chemotherapy
      • Radiation Therapy
      • Multimodal Therapy
      • Medications
      • Palliative Treatment
    • Find Top Doctors
      • Doctors
      • Treatment Centers
      • Treatment & Doctors Near You
      • New Treatments
      • Care Providers
      • Clinical Trials
      • Costs
  • Asbestos Trusts
  • Compensation
  • Veteran Assistance
    • Mesothelioma and Veterans
      • VA Claims for Mesothelioma
      • Vietnam Veterans
    • Military Branches and Asbestos
      • Navy Veterans
      • Navy Ships
      • Marine Corps Veterans
      • Army Veterans
      • Air Force Veterans
      • U.S. Coast Guard
  • Surviving Mesothelioma
  • About Us / Contact
  • Home
  • ›
  • Malignant Mesothelioma
  • ›
  • Types
  • ›
  • Peritoneal
Page Updated: June 27, 2022

Malignant Peritoneal Mesothelioma

Paul Sugarbaker, M.D. Page Medically Reviewed and Edited by Paul Sugarbaker, M.D.
Fact Checked

This page has been fact checked by a Medical Doctor who specializes in mesothelioma. Sources of information are listed at the bottom of the article.

We make every attempt to keep our information accurate and up-to-date.

Please Contact Us with any questions or comments.

Malignant peritoneal mesothelioma is the second most common form of mesothelioma cancer and occurs in the tissue that lines the abdominal cavity and organs.[1] The symptoms include pain and abdominal distention from ascites. Prognosis is poor, but aggressive and early treatment can extend a patient’s life and even provide a cure for some. 

Free Peritoneal Mesothelioma Packet

What Is Malignant Peritoneal Mesothelioma?

Peritoneal mesothelioma is a cancer of the peritoneum.[1] It is also known as peritoneal cancer.

The peritoneum is a thin membrane that creates the lining of the abdominal cavity, arising from mesothelial cells. It consists of two thin layers called the visceral peritoneum and the parietal peritoneum.[2]

Facts About Peritoneal Mesothelioma

Because this cancer is so rare, most people don’t know much about it. Here are some quick facts about peritoneal mesothelioma:[1]

  • All types of mesothelioma are aggressive and spread rapidly.
  • Known asbestos exopsure occurs in only about half of all cases of peritoneal mesothelioma.
  • Women, especially those without past asbestos exposure, account for most cases of multicystic and well-differentiated peritoneal mesothelioma. These types have long survival times.
  • Mesothelioma is rare, accounting for about 3,000 cases of cancer per year. Of those only 200 to 400 are peritoneal mesothelioma.
  • The highest numbers of diagnoses occur in people between the ages of 50 and 69.
  • Between 2% and 5% of peritoneal mesothelioma cases occur in people aged 20 or younger.
  • Survival time is often longer for peritoneal mesothelioma than pleural mesothelioma.

What Causes This Type of Mesothelioma?

patient doctor looking at tablet

The main cause of any type of mesothelioma is asbestos exposure.[1] The longer and more frequent the exposure, the greater the risk of developing mesothelioma.

Experts believe other risk factors, like genetics and family history, also play a role because not everyone exposed to asbestos develops cancer.[3] Also, some patients with peritoneal mesothelioma have no known history of asbestos exposure.

Prolonged asbestos exposure is most often associated with pleural mesothelioma because exposure is usually through inhalation of the fibers, but it can also trigger the peritoneal form in the abdomen.

There are two possible ways that asbestos fibers may travel to the abdominal cavity and cause peritoneal cancer:[3][4]

  • Asbestos fibers may also be ingested and may be present in the sputum. Over time, these fibers reach the peritoneal surface by penetrating the wall of the intestine. This process can ultimately lead to the development of cancerous cells.
  • Fibers that have been inhaled may also migrate through the lymphatic system and end up in the abdomen where they cause damage.

How Peritoneal Mesothelioma Develops

Whether they get there through inhalation or ingestion, asbestos fibers in the abdomen become embedded in the peritoneum cells. There they trigger inflammation and damage.

Cellular damage can lead to those cells becoming cancerous, growing, and dividing out of control. They then develop into tumors that may spread further through the peritoneum and to other tissues and organs.

What if I Was Never Exposed to Asbestos?

Peritoneal differs from the pleural form of mesothelioma in that more patients report no exposure to asbestos. Asbestos causes cancer typically by inhalation of the fibers, which is why pleural mesothelioma is more common.

Approximately half of all people diagnosed with the peritoneal form have no known past asbestos exposure. There may be several explanations for this:[1]

  • They did encounter asbestos in the past but didn’t realize it.
  • They experienced asbestos exposure second-hand, for instance, by living with someone who works around asbestos and unintentionally brings fibers home on clothing or in hair.
  • There may be other causes of mesothelioma, such as genetics, radiation exposure, or exposure to a virus known as SV40.

If you have symptoms of peritoneal mesothelioma but no known exposure, doctors will eliminate other, more likely causes first.

Why Are Women More Likely to Get Peritoneal Mesothelioma?

The majority of cases of both pleural and peritoneal mesothelioma are in men. However, more women receive diagnoses of peritoneal than pleural mesothelioma. Men are at greater risk because of their prevalence in workplaces that used asbestos.

Young women, in particular, make up most cases of multicystic and well-differentiated peritoneal mesothelioma. Experts don’t know why, but they suspect fibromatosis, a benight growth that affects women, may be a contributing factor.[1]

The good news for women with these types of peritoneal mesothelioma is that they are not aggressive and rarely metastasize. Surgery is often curative.

What Are the Symptoms of Peritoneal Mesothelioma?

Icon of Abdomen

The symptoms of peritoneal mesothelioma may not be obvious, or they may be mild and not show until many years, even decades, after asbestos exposure. Significant and harmful delays in diagnosis often occur for this reason. Peritoneal mesothelioma may cause:[5]

  • Ascites, fluid build up and swelling in the abdomen
  • Abdominal pain
  • Unintentional and unexplained weight loss
  • Diarrhea
  • Constipation
  • Bowel obstruction
  • Anemia
  • Fever
  • Fatigue
  • Nausea
  • Vomiting

How Is Peritoneal Mesothelioma Diagnosed?

The early symptoms of peritoneal mesothelioma make it challenging to diagnose. They are similar to symptoms of irritable bowel syndrome, Crohn’s disease, colitis, and other more common gastrointestinal disorders.

Doctors are more likely to diagnose these first, leading to a misdiagnosis. This is especially likely if they are unaware of any asbestos exposure a patient may have experienced.

The first step in getting an accurate diagnosis is a physical exam and a thorough history. Tell your healthcare provider if you have or think you may have experienced asbestos exposure. These steps will follow a physical exam in most cases:[6]

  • After reviewing your symptoms and performing a physical exam, your doctor may start ordering imaging studies, usually beginning with a simple X-ray or CT scan. These studies can help identify peritoneal changes, such as thickening of the lining, or a tumor mass to suggest the presence of cancer. Other specialized imaging such as MRI or PET/CT scans are usually ordered by specialty providers and may take place after a biopsy.
  • A blood test may also be used to determine if you have any tumor markers, any substances that are associated with cancer.
  • If there are visible abnormalities on a scan, a biopsy is used to determine a diagnosis. This is usually done by an interventional radiologist, a specialist trained in both reading imaging scans and performing minimally invasive biopsies. Most biopsies can be performed at a local hospital with patients going home the same day.
  • In some cases, a more invasive surgical biopsy may be necessary. This happens when the tissue in question is difficult to reach or the routine biopsy could not gather enough cells to give your medical team a firm diagnosis.

At this point, a surgeon will usually recommend a laparoscopy in the operating room under general anesthesia. This allows the surgeon to use a camera to look inside the abdominal cavity looking for any signs of cancer, and choose the best location to biopsy.

Laparoscopy is an excellent instrument by which the surgeon can directly visualize tumors within the abdomen and pelvis and also facilitate a biopsy of a cancerous nodule. However, it has been associated with mesothelioma growing out of the insertion site for the telescope. This is referred to as port site metastases.

In order to avoid this very serious dissemination of mesothelioma to the abdominal wall, laparoscopy for mesothelioma must only be performed through the absolute midline of the abdomen. Usually, the telescopy is placed just above or below the umbilicus. If cancer grows out at a midline port site, it can be excised without excessive damage to the muscles, nerves, and fascia that make up the abdominal wall.

Staging Peritoneal Mesothelioma

Staging cancer is important for giving patients an estimated prognosis or life expectancy and for informing treatment. Due to its rarity, peritoneal mesothelioma has no official staging system.

Many doctors rely on the TNM system used for pleural mesothelioma to designate a stage:[7]

  • Stage I. Tumors are only in the peritoneum and are limited.
  • Stage II. By stage II, tumors have grown and spread but have still not invaded the lymph nodes.
  • Stage III. When tumors spread outside the peritoneum or invade the lymph nodes, the stage is often labeled as III.

Some doctors include a fourth stage, which describes metastatic cancer.

Can Peritoneal Mesothelioma Be Misdiagnosed?

Peritoneal mesothelioma is extremely rare, and most doctors–even oncologists–have no experience with it. The symptoms can be vague and similar to other illnesses, and many people don’t have past exposure to asbestos as a clue.

For all these reasons, misdiagnosis is common. Typical misdiagnoses include hernia, irritable bowel syndrome, Crohn’s disease and colitis, ovarian cysts or cancer, and other types of abdominal cancer.

It’s essential that you seek a second opinion if you don’t feel good about a diagnosis you receive. If doctors have ruled out more common illnesses, see an oncologist or mesothelioma specialist.

How Is Peritoneal Mesothelioma Treated?

patient chemotherapy

Treatment options for peritoneal mesothelioma include the standard therapies of surgery; chemotherapy; radiation is seldom indicated. There are, as well, some new and experimental therapies.

Oncologists, especially those who specifically work with mesothelioma patients, are best suited to plan your treatments. They will most likely recommend a combination of therapies based on your cancer’s stage, your health and age, and your preferences.[7]

Cytoreductive Surgery and HIPEC

A newer, innovative treatment has been used with more success in patients with peritoneal mesothelioma and is now the standard therapy. It is called cytoreductive surgery plus HIPEC, or heated intraperitoneal chemotherapy:[8]

  • Cytoreductive surgery. The first step in this procedure is a radical surgery to remove as much cancerous tissue as possible. Completer removal gives the best results.
  • Heated chemotherapy. Then heated chemotherapy drugs are administered directly into the abdomen at the end of surgery.

Chemotherapy

Some patients are not good candidates for surgery and may benefit from systemic chemotherapy. A typical first-line treatment combination is pemetrexed with cisplatin or carboplatin. Although not as effective as surgery with HIPEC, systemic chemotherapy extends life expectancy for patients with peritoneal mesothelioma.

Advances in Immunotherapy

Researchers at MD Anderson Cancer Center recently reported positive results in clinical trials using immunotherapy drugs for peritoneal mesothelioma patients. These medications enhance the immune system in various ways to help target cancer cell death.

In a phase II clinical trial, the researcher got a positive response in 40% of participants. It extended survival time in these patients. The treatment also proved safe. This trial used the combination of atezolizumab and bevacizumab.[9]

Can Peritoneal Mesothelioma Be Cured?

All cases of mesothelioma are considered incurable, but some patients survive for many years and may be considered cured. This outcome is more likely in peritoneal than pleural mesothelioma.

One reason is that peritoneal mesothelioma spreads less aggressively. It also responds well to the novel HIPEC treatment after cytoreductive surgery, a treatment not yet found to be beneficial to pleural patients.

Who Are the Leading Peritoneal Mesothelioma Doctors?

Paul Sugarbaker, M.D.

Dr. Paul Sugarbaker is one of the world’s leading experts on peritoneal mesothelioma. He also specializes in treating cancers that have metastasized to the peritoneum. He is the Chief of the Peritoneal Surface Malignancy Program at Washington, D.C.’s Washington Hospital Center. He is also the Director of the Center for Gastrointestinal Malignancies.

During his career, Dr. Sugarbaker has worked both in clinical practice and research, including a decade as a Senior Investigator at the National Cancer Institute. He pioneered a treatment strategy for peritoneal mesothelioma, now known as the Sugarbaker Procedure. It involves using cytoreductive surgery followed by circulating heated chemotherapy drugs (HIPEC) throughout the abdominal cavity. The procedure is now used widely and has helped extend the life expectancy of many peritoneal cancer patients.

Paul Sugarbaker, M.D.

Kiran Turaga, M.D.

Dr. Kiran Turaga is a surgical oncologist with a special interest in treating advanced malignancies, including metastatic cancers (cancers that have spread beyond their original site to other parts of the body). Dr. Turaga has published widely on peritoneal mesothelioma.

He is the Professor of Surgical Oncology at the University of Chicago. He recently constructed a working group to provide multidisciplinary recommendations for the treatment of peritoneal mesothelioma. His guidelines were developed with input from leading experts, including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. His work has increased awareness of this disease and provided appropriate management strategies for malignant peritoneal mesothelioma. 

Dr. Turaga is an expert in regional perfusion, including hyperthermic intraperitoneal chemotherapy (HIPEC), a technique that delivers high doses of heated chemotherapy directly to abdominal organs to kill cancer cells that may remain after surgical removal of visible tumors.

He is highly skilled in minimally invasive approaches, including robotic surgery. He uses these innovative techniques to surgically treat and remove life-threatening cancers with smaller incisions and shorter recovery times.

Dr. Turaga is an avid and influential researcher who has published over 100 peer-reviewed articles and is an international authority on peritoneal surface disease. His clinical research focuses on the development of novel diagnostics and therapeutics for oligo-metastatic cancer. He is also interested in studying how big data systems can provide the most optimal, cost-effective patient care.

Kiran Turaga, M.D.

Andrew Blakely, M.D.

Dr. Andrew Blakely is a surgical oncologist specializing in peritoneal surface and retroperitoneal malignancies. A primary focus of his research is to develop novel treatment approaches and modalities to improve pre-operative treatment of peritoneal carcinomatosis.

Currently, Dr. Blakely is a Senior Investigator at the Surgery Branch, National Cancer Institute in Bethesda, Maryland. He is the surgeon designated to work with the multidisciplinary team at the National Institutes of Health on clinical and research studies in malignant peritoneal mesothelioma. Protocols for managing peritoneal mesothelioma are open at the National Institutes of Health and promise to bring new information to bear on this rare disease.

Andrew Blakely, M.D.

David Bartlett, M.D.

Dr. David Bartlett is currently Professor of Surgery and Director of the Surgical Oncology Program at the Allegheny Medical and Surgical Network. He has extensive experience treating peritoneal mesothelioma that began two decades ago at the National Institutes of Health.

He has published his data on the management of peritoneal mesothelioma widely in the peer-reviewed literature and is currently engaged in clinical and experimental research with this disease.

Dr. Bartlett served as a Senior Investigator at the Surgery Division of the Center for Cancer Research at the National Cancer Institute, where he developed innovative surgical techniques to treat patients with peritoneal metastases. He is currently President of the Society of Surgical Oncology. 

David Bartlett, M.D.

What Are the Best Treatment Centers for Peritoneal Mesothelioma?

To get the best outcome for this rare disease, you need specialist treatment. Not many oncologists or surgeons specialize in peritoneal mesothelioma. You may need to travel to one of these renowned cancer centers for the best treatment options:

  • MD Anderson Cancer Center, Houston, Texas
  • Washington Cancer Institute, Washington, D.C.
  • The University of Chicago Comprehensive Cancer Center, Chicago, Illinois
  • Herbert Irving Comprehensive Cancer Center, New York City

How Long Can I Live with Peritoneal Mesothelioma?

The prognosis for peritoneal mesothelioma is generally poor given the aggressive nature of the disease. However, it is usually much better than the outlook for pleural mesothelioma. Overall prognosis improves if you are a candidate for cytoreductive surgery plus HIPEC.[10]

Several factors determine each patient’s prognosis:

  • Age and health
  • Gender
  • Stage of the cancer at diagnosis
  • Treatments chosen
  • Concerning radiological features on CT identified by an experienced radiologist.

For peritoneal mesothelioma, the median survival time without disease progression–that is, the time a patient lives from diagnosis with no further worsening of the disease–is just 13.9 months.[10]

By stage, the five-year survival rates for peritoneal mesothelioma are:[7]

  • Stage I – 87%
  • Stage II – 53%
  • Stage III – 29%

How to Improve Prognosis

The best chance you have of a good prognosis for peritoneal mesothelioma is with an early diagnosis. Finding out about it in the early stages gives you more treatment options. Aggressive, early treatments can increase the amount of time patients spend without visible cancer and allow patients to feel good longer.

It is important to discuss the potential risks and complications with your medical care team to ensure you make the right decision. Choosing a team that has experience with mesothelioma can be very helpful.

The best survival rates are seen with patients who undergo cytoreductive surgery plus HIPEC. A 2017 study involved twenty-nine mesothelioma patients who received surgery followed by heated chemotherapy. Nearly three-quarters of the patients lived longer than five years after treatment, a big improvement in overall survival times.[8]

Getting a diagnosis for peritoneal mesothelioma may be devastating, but you have options and hope. You may get a second opinion and then seek treatment at a Peritoneal Surface Oncology center.

You can choose from aggressive treatments and those that will make you feel more comfortable in the time you have left. You may also be able to file a lawsuit to seek compensation if you were exposed to asbestos in the workplace.

Get Your FREE Mesothelioma Packet

Frequently Asked Questions

What Causes Peritoneal Mesothelioma?
The leading cause of any type of mesothelioma is asbestos exposure. Ingested fibers of asbestos cause irritation and damage that may lead to tumor growth in the peritoneum. Not everyone exposed to the mineral will develop cancer. Other risk factors involved include family history and genetics and radiation therapy to the abdomen.
What Are the Symptoms of Peritoneal Mesothelioma?
The common symptoms of peritoneal mesothelioma are abdominal swelling and distension from ascites and abdominal pain. Other symptoms include nausea, a feeling of fullness, and unintended weight loss. Rare symptoms may include hernia, fever, and night sweats.
How Long Can You Live with Peritoneal Mesothelioma?
Survival time varies based on cancer stage, patient health and age, and treatment chosen. Life expectancy is generally longer than for pleural mesothelioma. If treatments are not available to you, survival may be less than a year. Survival rate for peritoneal mesothelioma after one year is 50%, after two years 35%, and after five years, just 18%.
Is Peritoneal Mesothelioma Curable?
Most cases of mesothelioma are considered incurable, but often manageable. Patients with the best hope of being cured of peritoneal mesothelioma receive a diagnosis in an early stage, are younger and in good health, and are able to undergo aggressive treatment. Even with remission, the cancer may return later.
How Quickly Does Peritoneal Mesothelioma Spread?
The low survival rates for mesothelioma indicate how rapidly it spreads. This is an aggressive type of cancer that metastasizes readily within the peritoneal cavity. How fast it spreads depends on the cell type. In one study, patients with the epithelioid type of peritoneal mesothelioma had a median survival time of fifty-five months, while those with a biphasic type saw a median survival time of just thirteen months.
Get Your FREE Mesothelioma Packet

Page Medically Reviewed and Edited by Paul Sugarbaker, M.D.

Paul Sugarbaker, M.D.

Dr. Paul Sugarbaker is a leading expert in surgical oncology. He specializes in the surgical treatment of gastrointestinal cancers, peritoneal mesothelioma, and peritoneal metastases. He developed and advanced an important treatment procedure for peritoneal cancers and metastases known as HIPEC. The innovative strategy uses surgery followed by the circulation of heated chemotherapy drugs in the abdomen. Dr. Sugarbaker currently heads up the Peritoneal Surface Malignancy Program and the Center for Gastrointestinal Malignancies at Washington Hospital Center. He also works out of a private practice, Sugarbaker Oncology Associates.

Connect with Mesothelioma Doctor Paul Sugarbaker, M.D.
References
  1. Bridda, A., Padoan, I., Mencarelli, R. and Frego, M. (2007, May 10). Peritoneal Mesothelioma: A Review. MedGenMed. 9(2), 32.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994863/
  2. Kalra, A. and Tuma, F. (2018, November 26). Anatomy, Abdomen, and Pelvis, Peritoneum. StatPearls.
    Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK534788/
  3. Kanarek, M.S. and Mandich, M.K. (2016, March 29). Peritoneal Mesothelioma and Asbestos: Clarifying the Relationship by Epidemiology. Epidemiology. doi:10.4172/2161-1165.1000233.
    Retrieved from: https://www.omicsonline.org/open-access/peritoneal-mesothelioma-and-asbestos-clarifying-the-relationship-byepidemiology-2161-1165-1000233.php?aid=72695
  4. The American Cancer Society. (2018, November 16). What Causes Malignant Mesothelioma?
    Retrieved from: https://www.cancer.org/cancer/malignant-mesothelioma/causes-risks-prevention/what-causes.html
  5. American Cancer Society. (2018, November 16). Signs and Symptoms of Mesothelioma.
    Retrieved from: https://www.cancer.org/cancer/malignant-mesothelioma/detection-diagnosis-staging/signs-symptoms.html
  6. Sugarbaker, P.H, Turaga, K.K., Alexander, H.R., Deraco, M. & Hesdorffer, M. (2016). Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy. Journal of Oncology Practice, 12(10), 928-35.
    Retrieved from: https://ascopubs.org/doi/full/10.1200/jop.2016.011908
  7. Kim, J., Bhagwandin, S. & Labow, D.M. (2017). Malignant Peritoneal Mesothelioma: A Review. Annals of Translational Medicine, 5(11), 236.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497105/
  8. Lemoine, L., Sugarbaker, P., and Van der Speeten, K. (2017). Drugs, Doses, and Durations of Intraperitoneal Chemotherapy: Standardising HIPEC and EPIC for Colorectal, Appendiceal, Gastric, Ovarian Peritoneal Surface Malignancies and Peritoneal Mesothelioma. International Journal of Hypothermia. 33(5), 582-92.
    Retrieved from: https://www.tandfonline.com/doi/full/10.1080/02656736.2017.1291999
  9. MD Anderson Cancer Center. (2021, July 14). Atezolizumab and Bevacizumab Show Meaningful Responses for Malignant Peritoneal Mesothelioma Patients.
    Retrieved from: https://www.mdanderson.org/newsroom/atezolizumab-and-bevacizumab-show-meaningful-responses-for-malignant-peritoneal-mesothelioma-patients.h00-159462423.html
  10. Magge, D., Zenati, M.S., Austin, F., Mavanur, A., Sathaiah, M., Ramalingam, L., Jones, H., Zureikat, A.H., Holtzman, M., Ahrendt, S., Pingpank, J., Zeh, H.J., Bartlett, D.L. and Choudry, H.A. (2014, April). Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis. Ann. Surg. Oncol. 21(4), 1159-65.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/24322529
View All References
Jump To a Topic
  • What Is Malignant Peritoneal Mesothelioma?
  • Facts About Peritoneal Mesothelioma
  • What Causes This Type of Mesothelioma?
  • How Peritoneal Mesothelioma Develops
  • What if I Was Never Exposed to Asbestos?
  • Why Are Women More Likely to Get Peritoneal Mesothelioma?
  • What Are the Symptoms of Peritoneal Mesothelioma?
  • How Is Peritoneal Mesothelioma Diagnosed?
  • Staging Peritoneal Mesothelioma
  • Can Peritoneal Mesothelioma Be Misdiagnosed?
  • How Is Peritoneal Mesothelioma Treated?
  • Who Are the Leading Peritoneal Mesothelioma Doctors?
  • What Are the Best Treatment Centers for Peritoneal Mesothelioma?
  • How Long Can I Live with Peritoneal Mesothelioma?
  • How to Improve Prognosis
  • Frequently Asked Questions
  • Where Can I Get Additional Help?

Site Navigation

Home
Malignant Mesothelioma
How to Survive Mesothelioma
100 Questions & Answers about Mesothelioma (Free Book)
Surviving Mesothelioma - Beating the Odds (Free Book)
FREE Mesothelioma Packet
Symptoms
Shortness of Breath
Cough
Night Sweats and Fever
Weight Loss
Pain
Difficulty Swallowing
Fatigue and Muscle Weakness
Gastrointestinal Complications
Diagnosis
Pathology
Staging
Stage 1
Stage 2
Stage 3
Stage 4
Metastasis and Progression
Brain Metastasis
Biopsy
miRview Test
Imaging
Fine Needle Aspiration Biopsy in Mesothelioma
Biomarkers and Blood Tests
Calretinin
Prognosis
Remission
Recurrence
Death Rate
Life Expectancy
Search for a Mesothelioma Cure
Types
Pleural
Peritoneal
Epithelioid
Sarcomatoid
Biphasic
Pericardial
Testicular
Cell Types
Rare Subtypes of Mesothelioma
Deciduoid
Desmoplastic
Heterologous
Lymphohistiocytoid
Well-Differentiated Papillary
Tubulopapillary
Small Cell
Benign
Adenomatoid
Cystic
Unresectable
Localized
Idiopathic
Omental
Causes
Risk Factors
Latest Research
Genetic Components
Incidence
Latency Period
Mesothelioma Tumor
Health Insurance Coverage
Related Conditions
Immunodeficiency Disorders
Cholangiocarcinoma
Atelectasis
Pleural Plaques
Pleural Thickening
Pleural Effusion
Peritoneal Effusion (Ascites)
Mesothelial Hyperplasia and Proliferation
Pleuritis and Pleurisy
COPD
Anemia
Breast Cancer
Prevention
Complications
Misdiagnosis
Mesothelioma Commercial
Talcum Baby Powder
Lawyer
Lawsuits
Class Action Lawsuits
Settlements
Simian Virus 40
Differences From Other Cancers
Lung Cancer
Women
Children and Young Adults
Unknown Asbestos Exposure
Mesothelioma Without Asbestos
Cause of Death
Facts 
History
Awareness
Government and Research
National Mesothelioma Virtual Bank
Support
What to Expect
Living with Mesothelioma
Help a Loved One
Wrong and Right Things to Say
Caregivers
Financial Tips
Faith
Nutrition and Lifestyle
Intimacy
Mesothelioma and Fertility in Men
Fertility in Women with Mesothelioma
Emotional Health
COVID-19
Assisted Living
Hospice Care
Dying from Mesothelioma
Mourning
Coping Guide for Children
End-of-Life Decisions
Mesothelioma Awareness Day
Compensation for Victims
Lawyer
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington D.C.
Washington
West Virginia
Wisconsin
Wyoming
Lawsuit
Settlements
Statute of Limitations
Treatment
Surgery
Side Effects
Pneumonectomy
Extrapleural Pneumonectomy
Lobectomy
Pleurectomy / Decortication
Post Op Care
Pleurectomy / Decortication vs. Extrapleural Pneumonectomy
Peritonectomy/Cytoreductive Surgery
Thoracotomy
Thoracoscopy
Pericardiectomy
Wedge Resection
Pleurodesis
Pericardiocentesis
Prosthetics
Paracentesis
Thoracentesis
Chemotherapy
Side Effects
Heated Intraperitoneal
Radiation Therapy
Side Effects
Intensity-Modulated
Brachytherapy
Proton Therapy
Image-Guided
External Beam
Three-Dimensional
Multimodal Therapy
New Treatments
SMART Protocol
Gene Therapy
Suicide Gene Therapy
Tumor-Based p53 Therapy
Cryotherapy for Mesothelioma
Tumor Treating Fields
MicroRNA
Palliative Treatment
Osteopathic
Doctors
Treatment Centers
Treatment & Doctors Near You
Mesothelioma Experts
Medications
Alimta (pemetrexed)
Adriamycin (doxorubicin)
Avastin (bevacizumab)
Cytoxan (cyclophosphamide)
Gemzar (gemcitabine)
Keytruda (Pembrolizumab)
Mitomycin
Navelbine (vinorelbine)
Opdivo (nivolumab) and Yervoy (ipilimumab)
Paraplatin (carboplatin)
Platinol (cisplatin)
Rheumatrex (methotrexate)
Sutent (sunitinib)
Taxol (paclitaxel)
Medical Marijuana
Care Providers
Clinical Trials
Anetumab Ravtansine
Atezolizumab
Chimeric Antigen Receptor (CAR) T-Cell
Durvalumab
Immunotoxin
Interferon Alfa-2b
Onconase (Ranpirnase)
VISTA Protein
Costs
Immunotherapy
Nanotechnology
Hyperbaric Oxygen Therapy
Home Medical Equipment
HMGB1 Secretion
Photodynamic Therapy
Targeted Therapies
Apoptosis
Stem Cells
Lung Transplantation
Body-Based Therapies
Alternative Therapies
Paul Kraus’s Method
Doctors and Treatment in Canada
Asbestos Trusts
Veterans
VA Claims for Mesothelioma
Vietnam Veterans
Military Branches and Asbestos
Navy Veterans
Navy Ships
Aircraft Carriers
Battleships
Destroyers
Asbestos on Navy Cruisers
Submarines
Amphibious Ships
Minesweepers
Auxiliary Ships
Marine Corps Veterans
Army Veterans
Air Force Veterans
U.S. Coast Guard
Asbestos
Occupational Exposure
Construction Workers
Shipyard Workers
Ship Repair
Steel Mill Workers
Industrial Workers
Boiler Workers
Power Plant Workers
Firefighters
Automotive Workers
Roofers
Oil Refineries
Mining
Transportation Industry
Machine Operators
Farmers and Agricultural Workers
Migrant Workers
Electrical Wiring
Labor Unions
Prisons
Chimneys, Furnaces, and Wood Stoves
Fiberglass Connection to Mesothelioma
Home Remodeling
School Buildings, Teachers
For Tech Students
Cancer
Lung Cancer
Pleural Based Cancers
Ovarian Cancer
Ovarian Cancer Lawsuits
Companies That Used Asbestos
Awareness and Education
Types of Asbestos & Mesothelioma Risk
Asbestosis
Interstitial Lung Disease
Smoking
Asbestos Ingestion
Exposure in a Natural Disaster
Ban Asbestos
Libby, Montana
Recycling Asbestos
Asbestos Detection
Legal Information by State
Canada
Mexico
United Kingdom
Australia
  • Malignant Mesothelioma
    • Treatment
    • Asbestos Trusts
  • Compensation
    • Veteran Assistance
    • Surviving Mesothelioma
  • FREE Mesothelioma Packet
    • Mesothelioma News
    • About Us / Contact
  • Privacy Policy
    • Disclaimer
    • Editorial Guidelines and Standards
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
The information provided by Mesothelioma.net is not a substitute for professional medical advice, diagnosis or treatment.

Mesothelioma.net

5430 LBJ Freeway Suite 1200
Dallas, Texas 75240

Serving mesothelioma victims nationwide

1-800-692-8608

  • facebook
  • twitter
© 2022 Mesothelioma.net